1.
Quadri M, Saitta C, Palamini S, Rebellato S, Watrin T, Tu J-W, Bhatia S, Borkhardt A, Palmi C, Biondi A, Cazzaniga G, Fazio G. Efficacy of the kinase inhibitor CHZ868 against JAK2 rearrangements in pediatric acute lymphoblastic leukemia. haematol [Internet]. 2020Sep.10 [cited 2026Apr.19];. Available from: https://haematologica.org/article/view/14115